Skip to main content

Table 4 Sensitivity and specificity to quantification method.

From: Quantification of late gadolinium enhanced CMR in viability assessment in chronic ischemic heart disease: a comparison to functional outcome

 

sens

spec

SEE*

2SD

0,72

0,55

28

3SD

0,72

0,57

21

4SD

0,64

0,65

25

5SD

0,68

0,64

14

6SD

0,70

0,65

9

7SD

0,65

1,00

9

8SD

0,65

1,00

7

FWHM

0,61

0,66

9

  1. * = segmental extent of enhancement (%) at optimal sensitivity and specificity.
Back to article page

Journal of Cardiovascular Magnetic Resonance

ISSN: 1532-429X

Contact us